Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Advances in Brief

  • Advances in Brief
    Role of Tyrosine Phosphorylation in Radiation-induced Activation of c-jun Protooncogene in Human Lymphohematopoietic Precursor Cells
    Heonjoo Park Chae, Lisa J. Jarvis and Fatih M. Uckun
    Cancer Res February 1 1993 53 (3) 447-451;

  • Advances in Brief
    Screening for Germ Line p53 Mutations in Children with Malignant Tumors and a Family History of Cancer
    L. Brugières, M. Gardes, C. Moutou, A. Chompret, V. Meresse, A. Martin, N. Poisson, F. Flamant, C. Bonaïti-Pellié, J. Lemerle and J. Feunteun
    Cancer Res February 1 1993 53 (3) 452-455;

  • Advances in Brief
    Delayed-Type Hypersensitivity Reactions to Tumor-associated Antigens in Colon Carcinoma Patients Immunized with an Autologous Tumor Cell/Bacillus Calmette-Guérin Vaccine
    Elisabeth Bloemena, Helen Gall, Janet H. Ransom, Nicholas Pomato, James H. Murray, Ebo Bos, Rik J. Scheper, Chris J. L. M. Meijer, Michael G. Hanna Jr. and Jan B. Vermorken
    Cancer Res February 1 1993 53 (3) 456-459;

  • Advances in Brief
    DNA-Protein Cross-Links in Welders: Molecular Implications
    Max Costa, Anatoly Zhitkovich and Paolo Toniolo
    Cancer Res February 1 1993 53 (3) 460-463;

  • Advances in Brief
    Interleukin 6 Stimulates the Production of Immunoreactive Endothelin 1 in Human Breast Cancer Cells
    Jun-ichi Yamashita, Michio Ogawa, Koichi Nomura, Shuichi Matsuo, Kazuo Inada, Shin-ichi Yamashita, Yasunari Nakashima, Tetsushi Saishoji, Sadamu Takano and Shoji Fujita
    Cancer Res February 1 1993 53 (3) 464-467;

  • Advances in Brief
    p53 Abnormalities in Different Subtypes of Human Sarcomas
    Å. Andreassen, T. Øyjord, E. Hovig, R. Holm, V. A. Flørenes, J. M. Nesland, O. Myklebost, J. Høie, Ø. S. Bruland, A-L. Børresen and Ø. Fodstad
    Cancer Res February 1 1993 53 (3) 468-471;

  • Advances in Brief
    Time Course of Induction of Metabolism of all-trans-Retinoic Acid and the Up-Regulation of Cellular Retinoic Acid-binding Protein
    Peter C. Adamson, John F. Boylan, Frank M. Balis, Robert F. Murphy, Karen A. Godwin, Lorraine J. Gudas and David G. Poplack
    Cancer Res February 1 1993 53 (3) 472-476;

Articles

  • Advances in Brief
    Role of Tyrosine Phosphorylation in Radiation-induced Activation of c-jun Protooncogene in Human Lymphohematopoietic Precursor Cells
    Heonjoo Park Chae, Lisa J. Jarvis and Fatih M. Uckun
    Cancer Res February 1 1993 53 (3) 447-451;

  • Advances in Brief
    Screening for Germ Line p53 Mutations in Children with Malignant Tumors and a Family History of Cancer
    L. Brugières, M. Gardes, C. Moutou, A. Chompret, V. Meresse, A. Martin, N. Poisson, F. Flamant, C. Bonaïti-Pellié, J. Lemerle and J. Feunteun
    Cancer Res February 1 1993 53 (3) 452-455;

  • Advances in Brief
    Delayed-Type Hypersensitivity Reactions to Tumor-associated Antigens in Colon Carcinoma Patients Immunized with an Autologous Tumor Cell/Bacillus Calmette-Guérin Vaccine
    Elisabeth Bloemena, Helen Gall, Janet H. Ransom, Nicholas Pomato, James H. Murray, Ebo Bos, Rik J. Scheper, Chris J. L. M. Meijer, Michael G. Hanna Jr. and Jan B. Vermorken
    Cancer Res February 1 1993 53 (3) 456-459;

  • Advances in Brief
    DNA-Protein Cross-Links in Welders: Molecular Implications
    Max Costa, Anatoly Zhitkovich and Paolo Toniolo
    Cancer Res February 1 1993 53 (3) 460-463;

  • Advances in Brief
    Interleukin 6 Stimulates the Production of Immunoreactive Endothelin 1 in Human Breast Cancer Cells
    Jun-ichi Yamashita, Michio Ogawa, Koichi Nomura, Shuichi Matsuo, Kazuo Inada, Shin-ichi Yamashita, Yasunari Nakashima, Tetsushi Saishoji, Sadamu Takano and Shoji Fujita
    Cancer Res February 1 1993 53 (3) 464-467;

  • Advances in Brief
    p53 Abnormalities in Different Subtypes of Human Sarcomas
    Å. Andreassen, T. Øyjord, E. Hovig, R. Holm, V. A. Flørenes, J. M. Nesland, O. Myklebost, J. Høie, Ø. S. Bruland, A-L. Børresen and Ø. Fodstad
    Cancer Res February 1 1993 53 (3) 468-471;

  • Advances in Brief
    Time Course of Induction of Metabolism of all-trans-Retinoic Acid and the Up-Regulation of Cellular Retinoic Acid-binding Protein
    Peter C. Adamson, John F. Boylan, Frank M. Balis, Robert F. Murphy, Karen A. Godwin, Lorraine J. Gudas and David G. Poplack
    Cancer Res February 1 1993 53 (3) 472-476;

  • Public Issues
    Trends in Program Project Grant Funding at the National Cancer Institute
    Samuel Broder and Mary Cushing
    Cancer Res February 1 1993 53 (3) 477-484;

  • Special Lecture
    Role of the BCR-ABL Oncogene in Human Leukemia: Fifteenth Richard and Hinda Rosenthal Foundation Award Lecture
    Owen N. Witte
    Cancer Res February 1 1993 53 (3) 485-489;

  • Biochemistry and Biophysics
    Induction of Topoisomerase I-mediated DNA Cleavage by a New Indolocarbazole, ED-110
    Tomoko Yoshinari, Akihiro Yamada, Daisuke Uemura, Kazuhiro Nomura, Hiroharu Arakawa, Katsuhisa Kojiri, Eisaku Yoshida, Hiroyuki Suda and Akira Okura
    Cancer Res February 1 1993 53 (3) 490-494;

  • Carcinogenesis
    Identification of Cellular Defect in UVS1, a UV-sensitive Chinese Hamster Ovary Mutant Cell Line
    Masayuki Numata, Hiroaki Hata, Tadahiro Shiomi, Tsukasa Matsunaga, Toshio Mori, Osamu Nikaido, Akira Yasui and Atsushi Oikawa
    Cancer Res February 1 1993 53 (3) 495-499;

  • Carcinogenesis
    Clonal Analysis of the Expression of Multiple Transformation Phenotypes and Tumorigenicity by Morphologically Transformed 10T1/2 Cells
    Gary J. Smith, William N. Bell and Joe W. Grisham
    Cancer Res February 1 1993 53 (3) 500-508;

  • Carcinogenesis
    Metabolic Activation of N-Hydroxy-2-aminofluorene and N-Hydroxy-2-acetylaminofluorene by Monomorphic N-Acetyltransferase (NAT1) and Polymorphic N-Acetyltransferase (NAT2) in Colon Cytosols of Syrian Hamsters Congenic at the NAT2 Locus
    David W. Hein, Mark A. Doll, Kevin Gray, Timothy D. Rustan and Ronald J. Ferguson
    Cancer Res February 1 1993 53 (3) 509-514;

  • Carcinogenesis
    Transformation-induced Alterations in the Regulation of Tyrosine Aminotransferase Expression in Fetal Rat Hepatocytes: Changes in Hormone Inducibility and the DNase-hypersensitive Site
    George C. T. Yeoh and Christopher J. Fisher
    Cancer Res February 1 1993 53 (3) 515-522;

  • Clinical Investigations
    Phase I and Pharmacokinetic Study of Taxotere (RP 56976) Administered as a 24-Hour Infusion
    D. Bissett, A. Setanoians, J. Cassidy, M. A. Graham, G. A. Chadwick, P. Wilson, V. Auzannet, N. Le Bail, S. B. Kaye and D. J. Kerr
    Cancer Res February 1 1993 53 (3) 523-527;

  • Endocrinology
    Selective Increase in Type II Estrogen-binding Sites in the Dysplastic Dorsolateral Prostates of Noble Rats
    Shuk-mei Ho and Margaret Yu
    Cancer Res February 1 1993 53 (3) 528-532;

  • Endocrinology
    Inhibition of Angiogenesis by Antiestrogens
    A. Gagliardi and D. C. Collins
    Cancer Res February 1 1993 53 (3) 533-535;

  • Epidemiology
    Vegetables, Fruit, and Lung Cancer in the Iowa Women's Health Study
    Kristi A. Steinmetz, John D. Potter and Aaron R. Folsom
    Cancer Res February 1 1993 53 (3) 536-543;

  • Experimental Therapeutics
    Reduced Glutathione Protects against Cisplatin-induced Neurotoxicity in Rats
    Frank P. T. Hamers, Jan H. Brakkee, Ennio Cavalletti, Michele Tedeschi, Laura Marmonti, Gabriella Pezzoni, Jan P. Neijt and Willem H. Gispen
    Cancer Res February 1 1993 53 (3) 544-549;

  • Experimental Therapeutics
    Characterization of Experimental Mitoxantrone Cardiotoxicity and Its Partial Inhibition by ICRF-187 in Cultured Neonatal Rat Heart Cells
    N. G. Shipp, Robert T. Dorr, David S. Alberts, Brenda V. Dawson and Mary Hendrix
    Cancer Res February 1 1993 53 (3) 550-556;

  • Experimental Therapeutics
    O-Phospho-l-tyrosine Inhibits Cellular Growth by Activating Protein Tyrosine Phosphatases
    Shrikant Mishra and Anne W. Hamburger
    Cancer Res February 1 1993 53 (3) 557-563;

  • Experimental Therapeutics
    Nitric Oxide/Nucleophile Complexes Inhibit the in Vitro Proliferation of A375 Melanoma Cells via Nitric Oxide Release
    Chris M. Maragos, Ji Ming Wang, Joseph A. Hrabie, Joost J. Oppenheim and Larry K. Keefer
    Cancer Res February 1 1993 53 (3) 564-568;

  • Experimental Therapeutics
    Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression
    Enrico Proietti, Elena Tritarelli, Lucia Gabriele, Ugo Testa, Giampaolo Greco, Elvira Pelosi, Marco Gabbianelli, Filippo Belardelli and Cesare Peschle
    Cancer Res February 1 1993 53 (3) 569-576;

  • Experimental Therapeutics
    Antisense DNA Inhibition of Tumor Growth Induced by c-Ha-ras Oncogene in Nude Mice
    Gary D. Gray, Olga M. Hernandez, Denise Hebel, Malcolm Root, Julio M. Pow-Sang and Eric Wickstrom
    Cancer Res February 1 1993 53 (3) 577-580;

  • Experimental Therapeutics
    Antitumor Activity of N1,N11-Bis(ethyl)norspermine against Human Melanoma Xenografts and Possible Biochemical Correlates of Drug Action
    Carl W. Porter, Ralph J. Bernacki, John Miller and Raymond J. Bergeron
    Cancer Res February 1 1993 53 (3) 581-586;

  • Experimental Therapeutics
    Markedly Improved Efficacy of Edatrexate Compared to Methotrexate in a High-Dose Regimen with Leucovorin Rescue against Metastatic Murine Solid Tumors
    F. M. Sirotnak, G. M. Otter and F. A. Schmid
    Cancer Res February 1 1993 53 (3) 587-591;

  • Immunology
    Molecular Basis of Complement Resistance of Human Melanoma Cells Expressing the C3-cleaving Membrane Protease p65
    Markus W. Ollert, Joseph V. Kadlec, Eugene C. Petrella, Reinhard Bredehorst and Carl-Wilhelm Vogel
    Cancer Res February 1 1993 53 (3) 592-599;

  • Immunology
    Improved Radioimmunotherapeutic Efficacy of an Anticarcinoma Monoclonal Antibody (131I-CC49) When Given in Combination with γ-Interferon
    John W. Greiner, Claudio Dansky Ullmann, Carol Nieroda, Chen-Feng Qi, Diane Eggensperger, Shinya Shimada, Seth M. Steinberg and Jeffrey Schlom
    Cancer Res February 1 1993 53 (3) 600-608;

  • Molecular Biology and Genetics
    Hypersensitivity of Human Lymphocytes to UV-B and Solar Irradiation
    Colin F. Arlett, Jillian E. Lowe, Susan A. Harcourt, Alastair P. W. Waugh, Jane Cole, Leendert Roza, Brian L. Diffey, Toshio Mori, Osamu Nikaido and Michael H. L. Green
    Cancer Res February 1 1993 53 (3) 609-614;

  • Molecular Biology and Genetics
    Tumor Necrosis Factor α and Interleukin 1α Induce Anchorage Independence in v-jun Transgenic Murine Cells
    Luc Vanhamme, Glenn M. Marshall, Andre C. Schuh, Martin L. Breitman and Peter K. Vogt
    Cancer Res February 1 1993 53 (3) 615-621;

  • Molecular Biology and Genetics
    Characterization of Sarcoma Cell Lines from v-jun Transgenic Mice
    Glenn M. Marshall and Luc Vanhamme
    Cancer Res February 1 1993 53 (3) 622-626;

  • Tumor Biology
    Differential Isolation of Normal Luminal Mammary Epithelial Cells and Breast Cancer Cells from Primary and Metastatic Sites Using Selective Media
    Stephen P. Ethier, Michael L. Mahacek, William J. Gullick, Thomas S. Frank and Barbara L. Weber
    Cancer Res February 1 1993 53 (3) 627-635;

  • Tumor Biology
    Growth Inhibition of a Human Colorectal Carcinoma Cell Line by Interleukin 1 Is Associated with Enhanced Expression of γ-Interferon Receptors
    Arthur B. Raitano and Murray Korc
    Cancer Res February 1 1993 53 (3) 636-640;

  • Tumor Biology
    Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues
    Samuel B. Ho, Gloria A. Niehans, Carolyn Lyftogt, Pei Sha Yan, David L. Cherwitz, Elizabeth T. Gum, Rajvir Dahiya and Young S. Kim
    Cancer Res February 1 1993 53 (3) 641-651;

  • Tumor Biology
    Suramin Inhibits Growth and Yet Promotes Insulin-like Growth Factor II Expression in HepG2 Cells
    Andrea Kraft, Lola M. Reid and Isabel Zvibel
    Cancer Res February 1 1993 53 (3) 652-657;

  • Tumor Biology
    Distribution of Colon Cancer Cells Permanently Labeled by Lectin-mediated Endocytosis of a Trap Label
    Christian Rushfeldt and Bård Smedsrød
    Cancer Res February 1 1993 53 (3) 658-662;

  • Tumor Biology
    Morphological and Functional Properties of TM Preneoplastic Mammary Outgrowths
    Daniel Medina, Frances S. Kittrell, Yong-Jian Liu and Marlene Schwartz
    Cancer Res February 1 1993 53 (3) 663-667;

  • Tumor Biology
    Growth Factor Dependency and Gene Expression in Preneoplastic Mouse Mammary Epithelial Cells
    Daniel Medina, Frances S. Kittrell, Carol J. Oborn and Marlene Schwartz
    Cancer Res February 1 1993 53 (3) 668-674;

  • Tumor Biology
    Functional Expression of Interleukin 2 Receptor in a Human Factor-dependent Megakaryoblastic Leukemia Cell Line: Evidence That Granulocyte-Macrophage Colony-stimulating Factor Inhibits Interleukin 2 Binding to Its Receptor
    Yuzuru Kanakura, Hiroyuki Sugahara, Hideki Mitsui, Hirokazu Ikeda, Takuma Furitsu, Hirosuke Yagura, Hitoshi Kitayama, Yoshio Kanayama and Yuji Matsuzawa
    Cancer Res February 1 1993 53 (3) 675-680;

  • Tumor Biology
    Chromosomes 8, 12, and 17 Copy Number in Astler-Coller Stage C Colon Cancer in Relation to Proliferative Activity and DNA Ploidy
    Melissa G. Steiner, Seth P. Harlow, Edoardo Colombo and Kenneth D. Bauer
    Cancer Res February 1 1993 53 (3) 681-686;

  • Tumor Biology
    Milky Spots as the Implantation Site for Malignant Cells in Peritoneal Dissemination in Mice
    Akeo Hagiwara, Toshio Takahashi, Kiyoshi Sawai, Hiroki Taniguchi, Masataka Shimotsuma, Shinji Okano, Chouhei Sakakura, Hiroyuki Tsujimoto, Kimihiko Osaki, Sadayuki Sasaki and Morio Shirasu
    Cancer Res February 1 1993 53 (3) 687-692;

  • Tumor Biology
    Melanoma-mediated Dissolution of Extracellular Matrix: Contribution of Urokinase-dependent and Metalloproteinase-dependent Proteolytic Pathways
    Anthony M. P. Montgomery, Yves A. De Clerck, Keith E. Langley, Ralph A. Reisfeld and Barbara M. Mueller
    Cancer Res February 1 1993 53 (3) 693-700;

  • Tumor Biology
    Adhesion of Metastatic, ras-transformed NIH 3T3 Cells to Osteopontin, Fibronectin, and Laminin
    Ann F. Chambers, Charulata Hota and Charles W. Prince
    Cancer Res February 1 1993 53 (3) 701-706;

  • Articles
    Announcements
    Cancer Res February 1 1993 53 (3) 707-709;

Public Issues

  • Public Issues
    Trends in Program Project Grant Funding at the National Cancer Institute
    Samuel Broder and Mary Cushing
    Cancer Res February 1 1993 53 (3) 477-484;

Special Lecture

  • Special Lecture
    Role of the BCR-ABL Oncogene in Human Leukemia: Fifteenth Richard and Hinda Rosenthal Foundation Award Lecture
    Owen N. Witte
    Cancer Res February 1 1993 53 (3) 485-489;

Biochemistry and Biophysics

  • Biochemistry and Biophysics
    Induction of Topoisomerase I-mediated DNA Cleavage by a New Indolocarbazole, ED-110
    Tomoko Yoshinari, Akihiro Yamada, Daisuke Uemura, Kazuhiro Nomura, Hiroharu Arakawa, Katsuhisa Kojiri, Eisaku Yoshida, Hiroyuki Suda and Akira Okura
    Cancer Res February 1 1993 53 (3) 490-494;

Carcinogenesis

  • Carcinogenesis
    Identification of Cellular Defect in UVS1, a UV-sensitive Chinese Hamster Ovary Mutant Cell Line
    Masayuki Numata, Hiroaki Hata, Tadahiro Shiomi, Tsukasa Matsunaga, Toshio Mori, Osamu Nikaido, Akira Yasui and Atsushi Oikawa
    Cancer Res February 1 1993 53 (3) 495-499;

  • Carcinogenesis
    Clonal Analysis of the Expression of Multiple Transformation Phenotypes and Tumorigenicity by Morphologically Transformed 10T1/2 Cells
    Gary J. Smith, William N. Bell and Joe W. Grisham
    Cancer Res February 1 1993 53 (3) 500-508;

  • Carcinogenesis
    Metabolic Activation of N-Hydroxy-2-aminofluorene and N-Hydroxy-2-acetylaminofluorene by Monomorphic N-Acetyltransferase (NAT1) and Polymorphic N-Acetyltransferase (NAT2) in Colon Cytosols of Syrian Hamsters Congenic at the NAT2 Locus
    David W. Hein, Mark A. Doll, Kevin Gray, Timothy D. Rustan and Ronald J. Ferguson
    Cancer Res February 1 1993 53 (3) 509-514;

  • Carcinogenesis
    Transformation-induced Alterations in the Regulation of Tyrosine Aminotransferase Expression in Fetal Rat Hepatocytes: Changes in Hormone Inducibility and the DNase-hypersensitive Site
    George C. T. Yeoh and Christopher J. Fisher
    Cancer Res February 1 1993 53 (3) 515-522;

Clinical Investigations

  • Clinical Investigations
    Phase I and Pharmacokinetic Study of Taxotere (RP 56976) Administered as a 24-Hour Infusion
    D. Bissett, A. Setanoians, J. Cassidy, M. A. Graham, G. A. Chadwick, P. Wilson, V. Auzannet, N. Le Bail, S. B. Kaye and D. J. Kerr
    Cancer Res February 1 1993 53 (3) 523-527;

Endocrinology

  • Endocrinology
    Selective Increase in Type II Estrogen-binding Sites in the Dysplastic Dorsolateral Prostates of Noble Rats
    Shuk-mei Ho and Margaret Yu
    Cancer Res February 1 1993 53 (3) 528-532;

  • Endocrinology
    Inhibition of Angiogenesis by Antiestrogens
    A. Gagliardi and D. C. Collins
    Cancer Res February 1 1993 53 (3) 533-535;

Epidemiology

  • Epidemiology
    Vegetables, Fruit, and Lung Cancer in the Iowa Women's Health Study
    Kristi A. Steinmetz, John D. Potter and Aaron R. Folsom
    Cancer Res February 1 1993 53 (3) 536-543;

Experimental Therapeutics

  • Experimental Therapeutics
    Reduced Glutathione Protects against Cisplatin-induced Neurotoxicity in Rats
    Frank P. T. Hamers, Jan H. Brakkee, Ennio Cavalletti, Michele Tedeschi, Laura Marmonti, Gabriella Pezzoni, Jan P. Neijt and Willem H. Gispen
    Cancer Res February 1 1993 53 (3) 544-549;

  • Experimental Therapeutics
    Characterization of Experimental Mitoxantrone Cardiotoxicity and Its Partial Inhibition by ICRF-187 in Cultured Neonatal Rat Heart Cells
    N. G. Shipp, Robert T. Dorr, David S. Alberts, Brenda V. Dawson and Mary Hendrix
    Cancer Res February 1 1993 53 (3) 550-556;

  • Experimental Therapeutics
    O-Phospho-l-tyrosine Inhibits Cellular Growth by Activating Protein Tyrosine Phosphatases
    Shrikant Mishra and Anne W. Hamburger
    Cancer Res February 1 1993 53 (3) 557-563;

  • Experimental Therapeutics
    Nitric Oxide/Nucleophile Complexes Inhibit the in Vitro Proliferation of A375 Melanoma Cells via Nitric Oxide Release
    Chris M. Maragos, Ji Ming Wang, Joseph A. Hrabie, Joost J. Oppenheim and Larry K. Keefer
    Cancer Res February 1 1993 53 (3) 564-568;

  • Experimental Therapeutics
    Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression
    Enrico Proietti, Elena Tritarelli, Lucia Gabriele, Ugo Testa, Giampaolo Greco, Elvira Pelosi, Marco Gabbianelli, Filippo Belardelli and Cesare Peschle
    Cancer Res February 1 1993 53 (3) 569-576;

  • Experimental Therapeutics
    Antisense DNA Inhibition of Tumor Growth Induced by c-Ha-ras Oncogene in Nude Mice
    Gary D. Gray, Olga M. Hernandez, Denise Hebel, Malcolm Root, Julio M. Pow-Sang and Eric Wickstrom
    Cancer Res February 1 1993 53 (3) 577-580;

  • Experimental Therapeutics
    Antitumor Activity of N1,N11-Bis(ethyl)norspermine against Human Melanoma Xenografts and Possible Biochemical Correlates of Drug Action
    Carl W. Porter, Ralph J. Bernacki, John Miller and Raymond J. Bergeron
    Cancer Res February 1 1993 53 (3) 581-586;

  • Experimental Therapeutics
    Markedly Improved Efficacy of Edatrexate Compared to Methotrexate in a High-Dose Regimen with Leucovorin Rescue against Metastatic Murine Solid Tumors
    F. M. Sirotnak, G. M. Otter and F. A. Schmid
    Cancer Res February 1 1993 53 (3) 587-591;

Immunology

  • Immunology
    Molecular Basis of Complement Resistance of Human Melanoma Cells Expressing the C3-cleaving Membrane Protease p65
    Markus W. Ollert, Joseph V. Kadlec, Eugene C. Petrella, Reinhard Bredehorst and Carl-Wilhelm Vogel
    Cancer Res February 1 1993 53 (3) 592-599;

  • Immunology
    Improved Radioimmunotherapeutic Efficacy of an Anticarcinoma Monoclonal Antibody (131I-CC49) When Given in Combination with γ-Interferon
    John W. Greiner, Claudio Dansky Ullmann, Carol Nieroda, Chen-Feng Qi, Diane Eggensperger, Shinya Shimada, Seth M. Steinberg and Jeffrey Schlom
    Cancer Res February 1 1993 53 (3) 600-608;

Molecular Biology and Genetics

  • Molecular Biology and Genetics
    Hypersensitivity of Human Lymphocytes to UV-B and Solar Irradiation
    Colin F. Arlett, Jillian E. Lowe, Susan A. Harcourt, Alastair P. W. Waugh, Jane Cole, Leendert Roza, Brian L. Diffey, Toshio Mori, Osamu Nikaido and Michael H. L. Green
    Cancer Res February 1 1993 53 (3) 609-614;

  • Molecular Biology and Genetics
    Tumor Necrosis Factor α and Interleukin 1α Induce Anchorage Independence in v-jun Transgenic Murine Cells
    Luc Vanhamme, Glenn M. Marshall, Andre C. Schuh, Martin L. Breitman and Peter K. Vogt
    Cancer Res February 1 1993 53 (3) 615-621;

  • Molecular Biology and Genetics
    Characterization of Sarcoma Cell Lines from v-jun Transgenic Mice
    Glenn M. Marshall and Luc Vanhamme
    Cancer Res February 1 1993 53 (3) 622-626;

Tumor Biology

  • Tumor Biology
    Differential Isolation of Normal Luminal Mammary Epithelial Cells and Breast Cancer Cells from Primary and Metastatic Sites Using Selective Media
    Stephen P. Ethier, Michael L. Mahacek, William J. Gullick, Thomas S. Frank and Barbara L. Weber
    Cancer Res February 1 1993 53 (3) 627-635;

  • Tumor Biology
    Growth Inhibition of a Human Colorectal Carcinoma Cell Line by Interleukin 1 Is Associated with Enhanced Expression of γ-Interferon Receptors
    Arthur B. Raitano and Murray Korc
    Cancer Res February 1 1993 53 (3) 636-640;

  • Tumor Biology
    Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues
    Samuel B. Ho, Gloria A. Niehans, Carolyn Lyftogt, Pei Sha Yan, David L. Cherwitz, Elizabeth T. Gum, Rajvir Dahiya and Young S. Kim
    Cancer Res February 1 1993 53 (3) 641-651;

  • Tumor Biology
    Suramin Inhibits Growth and Yet Promotes Insulin-like Growth Factor II Expression in HepG2 Cells
    Andrea Kraft, Lola M. Reid and Isabel Zvibel
    Cancer Res February 1 1993 53 (3) 652-657;

  • Tumor Biology
    Distribution of Colon Cancer Cells Permanently Labeled by Lectin-mediated Endocytosis of a Trap Label
    Christian Rushfeldt and Bård Smedsrød
    Cancer Res February 1 1993 53 (3) 658-662;

  • Tumor Biology
    Morphological and Functional Properties of TM Preneoplastic Mammary Outgrowths
    Daniel Medina, Frances S. Kittrell, Yong-Jian Liu and Marlene Schwartz
    Cancer Res February 1 1993 53 (3) 663-667;

  • Tumor Biology
    Growth Factor Dependency and Gene Expression in Preneoplastic Mouse Mammary Epithelial Cells
    Daniel Medina, Frances S. Kittrell, Carol J. Oborn and Marlene Schwartz
    Cancer Res February 1 1993 53 (3) 668-674;

  • Tumor Biology
    Functional Expression of Interleukin 2 Receptor in a Human Factor-dependent Megakaryoblastic Leukemia Cell Line: Evidence That Granulocyte-Macrophage Colony-stimulating Factor Inhibits Interleukin 2 Binding to Its Receptor
    Yuzuru Kanakura, Hiroyuki Sugahara, Hideki Mitsui, Hirokazu Ikeda, Takuma Furitsu, Hirosuke Yagura, Hitoshi Kitayama, Yoshio Kanayama and Yuji Matsuzawa
    Cancer Res February 1 1993 53 (3) 675-680;

  • Tumor Biology
    Chromosomes 8, 12, and 17 Copy Number in Astler-Coller Stage C Colon Cancer in Relation to Proliferative Activity and DNA Ploidy
    Melissa G. Steiner, Seth P. Harlow, Edoardo Colombo and Kenneth D. Bauer
    Cancer Res February 1 1993 53 (3) 681-686;

  • Tumor Biology
    Milky Spots as the Implantation Site for Malignant Cells in Peritoneal Dissemination in Mice
    Akeo Hagiwara, Toshio Takahashi, Kiyoshi Sawai, Hiroki Taniguchi, Masataka Shimotsuma, Shinji Okano, Chouhei Sakakura, Hiroyuki Tsujimoto, Kimihiko Osaki, Sadayuki Sasaki and Morio Shirasu
    Cancer Res February 1 1993 53 (3) 687-692;

  • Tumor Biology
    Melanoma-mediated Dissolution of Extracellular Matrix: Contribution of Urokinase-dependent and Metalloproteinase-dependent Proteolytic Pathways
    Anthony M. P. Montgomery, Yves A. De Clerck, Keith E. Langley, Ralph A. Reisfeld and Barbara M. Mueller
    Cancer Res February 1 1993 53 (3) 693-700;

  • Tumor Biology
    Adhesion of Metastatic, ras-transformed NIH 3T3 Cells to Osteopontin, Fibronectin, and Laminin
    Ann F. Chambers, Charulata Hota and Charles W. Prince
    Cancer Res February 1 1993 53 (3) 701-706;

Back to top
PreviousNext
February 1993
Volume 53, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Jump to

  • Advances in Brief
  • Articles
  • Public Issues
  • Special Lecture
  • Biochemistry and Biophysics
  • Carcinogenesis
  • Clinical Investigations
  • Endocrinology
  • Epidemiology
  • Experimental Therapeutics
  • Immunology
  • Molecular Biology and Genetics
  • Tumor Biology
Advertisement
  • Most Cited
  • Most Read
Loading
  • Towards Multidrug Adaptive Therapy
  • IL1β Promotes Immune Suppression in Pancreatic Cancer
  • SHP2 in Macrophages and Tumor Immunosuppression
  • Metabolomic Gradients in Glioblastoma Models
  • ATM Loss and Therapeutic Sensitivities in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement